Visible Clues and Hidden Risks: Physical Presentation
At a Glance
In HTNB, shortened fingers or toes, short stature, and subtle hand or foot X-ray changes can point to the syndrome, but severe high blood pressure may cause no symptoms. Regular accurate monitoring helps reduce the risk of stroke.
Understanding the physical signs of Brachydactyly-Arterial Hypertension Syndrome (HTNB) is a key part of managing the condition. Because many of the most serious effects happen internally, the visible physical traits often serve as the first “clues” that lead to a diagnosis [1][2].
The Hands and Feet: Brachydactyly Type E
The most visible sign of HTNB is a specific skeletal pattern called Brachydactyly Type E. This refers to the unusual shortening of the bones in the hands and feet [3].
- What you might notice: You may see that one or more of your fingers or toes appear shorter than others. This is usually most noticeable in the ring finger or the pinky, but it can affect any digit [3][4]. In some cases, the hands or feet may simply appear smaller overall.
- What a radiograph (X-ray) shows: While your hands may look normal to the casual observer, an X-ray can reveal that the metacarpals (the long bones in the palm) or metatarsals (the long bones in the foot) are significantly shorter than expected [5][3]. Doctors may also look for cone-shaped epiphyses; the epiphysis is the rounded end of a bone, which can sometimes have a distinctive triangular shape on an X-ray [6].
- Variability: It is important to know that these traits can vary widely, even among members of the same family [4][7]. Some people may have very obvious shortening, while others may only show subtle changes that require an X-ray to identify [8]. Remember that Brachydactyly Type E has several genetic causes and should prompt appropriate clinical and genetic evaluation rather than an automatic HTNB label.
The “Silent” Challenge: Severe Hypertension
The most critical feature of HTNB is severe high blood pressure. Unlike common hypertension, which is often linked to diet or lifestyle, the hypertension in HTNB is driven primarily by the genetic overactivity of the PDE3A gene in the blood vessel walls [5][9].
- Asymptomatic Nature: A defining—and dangerous—characteristic of this syndrome is that the hypertension is often “silent.” You may have extremely high blood pressure readings without feeling any physical symptoms like headaches or dizziness [9][10].
- The Danger of “Feeling Fine”: Because you may not feel sick, it can be tempting to underestimate the severity of the condition. However, untreated severe hypertension is associated with a high risk of stroke [2][10]. This is why routine, accurate blood pressure screening is essential for anyone with the characteristic skeletal signs, regardless of how they feel [2].
Home Blood Pressure Monitoring Guide
To monitor your blood pressure accurately at home:
- Use a validated, upper-arm cuff of the correct size.
- Rest quietly in a seated position for five minutes before measuring.
- Keep your back and feet supported, and rest your arm at heart level.
- Take two readings a minute apart, record them in a log, and bring the log to your visits.
- Do not adjust your medication doses based on a single home reading.
Height and Stature
Many people with HTNB also experience short stature [1][2]. This means you may be noticeably shorter than the average height for your age and sex, or significantly shorter than other biological family members who do not have the condition [1].
This height difference is tied to the same genetic mechanism that affects the bones in the hands and feet. The altered PDE3A signaling interferes with the pathways that regulate how long bones grow during childhood and adolescence [9][12]. While not everyone with HTNB is extremely short, “relative” short stature (being shorter than expected based on family history) is a common clinical finding [1].
Recognizing Potential Symptoms
While the condition is often silent, very high blood pressure can eventually cause symptoms if it reaches a critical level or begins to affect organs. You must call emergency services immediately for any of the following sudden symptoms:
- Sudden neurological deficits, like facial drooping, arm weakness, or slurred speech.
- Sudden severe headache [13].
- Sudden changes in vision or vision loss [14].
- Unexplained severe dizziness, confusion, or seizures [13].
- Severe chest pain or shortness of breath, especially when lying down or during mild activity [15].
Because the skeletal signs are present from birth or early childhood, they serve as a vital “red flag” that allows for early intervention before the hypertension causes internal damage [2].
| Physical Feature | What it Means for You |
|---|---|
| Shortened Digits | A visual marker that requires X-ray confirmation of Brachydactyly Type E [3]. |
| Short Stature | A common growth variation associated with the PDE3A mutation [1]. |
| Silent Hypertension | Severe high blood pressure that often has no symptoms but carries a high stroke risk if untreated [2]. |
| Increased Resistance | Blood vessels are more rigid, requiring medication selected and adjusted by a clinician experienced in severe or genetic hypertension [9][11]. |
Common questions in this guide
What does HTNB usually look like physically?
Does brachydactyly type E by itself diagnose HTNB?
Can HTNB cause very high blood pressure without symptoms?
What is the correct way to check my blood pressure at home?
What emergency warning signs can high blood pressure cause?
Why might someone with HTNB be shorter than family members?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Skeletal signs
Could an X-ray show whether my hand or foot bones are shorter than expected?
Blood pressure checks
Should I keep a home blood pressure log to bring to my visits?
Silent high blood pressure
Could high blood pressure cause no symptoms even when I feel fine?
Get notified when new evidence is published on Brachydactyly-arterial hypertension syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
PDE3A mutations cause autosomal dominant hypertension with brachydactyly.
Maass PG, Aydin A, Luft FC, et al.
Nature genetics 2015; (47(6)):647-53 doi:10.1038/ng.3302.
PMID: 25961942 - 2
Hypertension and Brachydactyly Syndrome Associated With Vertebral Artery Malformation Caused by a PDE3A Missense Mutation.
Fan P, Zhang D, Yang KQ, et al.
American journal of hypertension 2020; (33(2)):190-197 doi:10.1093/ajh/hpz151.
PMID: 31549136 - 3
Severe brachydactyly and short stature resulting from a novel pathogenic TRPS1 variant within the GATA DNA-binding domain.
Karaca A, Reyes M, Shumate LT, et al.
Bone 2019; (123()):153-158 doi:10.1016/j.bone.2019.03.028.
PMID: 30914275 - 4
Variable expressivity of the phenotype in two families with brachydactyly type E, craniofacial dysmorphism, short stature and delayed bone age caused by novel heterozygous mutations in the PTHLH gene.
Jamsheer A, Sowińska-Seidler A, Olech EM, et al.
Journal of human genetics 2016; (61(5)):457-61 doi:10.1038/jhg.2015.172.
PMID: 26763883 - 5
PDE3A variant associated with hypertension and brachydactyly syndrome in a patient with ischemic stroke caused by spontaneous intracranial artery dissection: A review of the clinical and molecular genetic features.
Lee CG, Kang K, Yoon RG, et al.
European journal of medical genetics 2020; (63(4)):103781 doi:10.1016/j.ejmg.2019.103781.
PMID: 31589936 - 6
[Clinical and genetic characteristics of 6 children with acrodysostosis].
Wang XO, Zhang T, Gong CX, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2026; (64(10)):1185-1189 doi:10.3760/cma.j.cn112140-20260530-00421.
PMID: 42742022 - 7
A novel heterozygous mutation in PTHLH causing autosomal dominant brachydactyly type E complicated with short stature.
Sun J, Yang N, Xu Z, et al.
Molecular genetics & genomic medicine 2024; (12(2)):e2393 doi:10.1002/mgg3.2393.
PMID: 38407575 - 8
What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis.
Pereda A, Garin I, , Perez de Nanclares G
BMC medical genetics 2018; (19(1)):32 doi:10.1186/s12881-018-0530-z.
PMID: 29499646 - 9
Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
Ercu M, Mücke MB, Pallien T, et al.
Circulation 2022; (146(23)):1758-1778 doi:10.1161/CIRCULATIONAHA.122.060210.
PMID: 36259389 - 10
Mutations in Phosphodiesterase 3A (PDE3A) Cause Hypertension Without Cardiac Damage.
Ercu M, Walter S, Klussmann E
Hypertension (Dallas, Tex. : 1979) 2023; (80(6)):1171-1179 doi:10.1161/HYPERTENSIONAHA.122.19433.
PMID: 37035914 - 11
Phosphodiesterase 3A and Arterial Hypertension.
Ercu M, Markó L, Schächterle C, et al.
Circulation 2020; (142(2)):133-149 doi:10.1161/CIRCULATIONAHA.119.043061.
PMID: 32524868 - 12
Personal Genetic-Hypertension Odyssey From Phenotypes to Genotypes and Targets.
Luft FC
Hypertension (Dallas, Tex. : 1979) 2024; (81(12)):2395-2406 doi:10.1161/HYPERTENSIONAHA.124.21714.
PMID: 39355912 - 13
A Prospective, Observational Study to Determine the Prevalence and Clinical Profile of Patients of Hypertensive Crisis in a Tertiary Care Hospital.
Salagre SB, Itolikar SM, Gedam K
The Journal of the Association of Physicians of India 2017; (65(6)):14-21.
PMID: 28782308 - 14
Clinical Characteristics of Hospitalized Pediatric Patients With Hypertensive Crisis-A Retrospective, Single-Center Study in China.
Ba H, Peng H, Xu L, et al.
Frontiers in cardiovascular medicine 2022; (9()):891804 doi:10.3389/fcvm.2022.891804.
PMID: 35711370 - 15
[Hypertensive emergencies and urgencies].
Phan DG, Dreyfuss-Tubiana C, Blacher J
Presse medicale (Paris, France : 1983) 2015; (44(7-8)):737-44.
PMID: 26248707
This page is for informational purposes only and does not constitute medical advice. A healthcare professional should evaluate possible HTNB, interpret X-rays, and set your blood pressure monitoring and treatment plan.